Search results
Ethereum Price Remains Flat Following Historic Spot ETF Approval
CoinMarketCap via Yahoo Finance· 17 hours agoEthereum (ETH), the second-largest cryptocurrency by market capitalization, experienced relatively...
Most Shareholders Will Probably Find That The Compensation For OpenLearning Limited's (ASX:OLL) CEO...
Simply Wall St. via Yahoo Finance· 1 hour agoAccording to our data, OpenLearning Limited has a market capitalization of AU$4.3m, and paid its CEO...
Arthur J. Gallagher & Co. director sells $219k in stock By Investing.com
Investing.com· 2 hours agoIn a recent transaction on May 22, Arthur J. Gallagher & Co. (NYSE:AJG) Director David S. Johnson...
We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 1 hour agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Was Angel Reese's now-deleted tweet a dig at Caitlin Clark?
NBC Sports Chicago via Yahoo Sports· 4 hours agoSky rookie Angel Reese fueled an contentious discourse surrounding Caitlin Clark and the 0-5 Indiana...
Exploring D'Ieteren Group And Two More Top Growth Companies With Major Insider Ownership
Simply Wall St. via Yahoo Finance· 1 hour agoAs global markets exhibit a mixed performance with the Dow Jones facing its steepest weekly drop...
Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
Zacks via Yahoo Finance· 11 hours agoSUSIX is part of the Large Cap Blend section, and these mutual funds most often invest in firms with...
Trump's Truth Social struggles to grow its user base, according to new data
NBC Universal via AOL· 47 minutes agoThe data firms’ findings could also harden Wall Street analysts’ view of the company as a “meme...
Nvidia stock is through the roof — Here's how to manage a potential correction By Investing.com
Investing.com· 3 hours agoNvidia (NASDAQ:NVDA) shares are skyrocketing. This surge follows the release of an impressive...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 7 hours agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...